Christine Ring Nurix Therapeutics, Inc. (NRIX) insider trading activity

Christine Ring is Chief Legal Officer of Nurix Therapeutics, Inc.. Currently has a direct ownership of 28,084 shares of NRIX, which is worth approximately $635,821. The most recent transaction as insider was on Nov 04, 2024, when has been sold 3,290 shares (Common Stock) at a price of $25.0 per share, resulting in proceeds of $82,250. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 28.1K

14.2% 3M change

84.0% 12M change

Total Value Held $635,821

Christine Ring Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Nov 04 2024	SELL Open market or private sale	$82,250 $25.0 p/Share	3,290 Reduced 10.49%	28,084 Common Stock
Nov 04 2024	BUY Exercise of conversion of derivative security	$31,485 $9.57 p/Share	3,290 Added 9.49%	31,374 Common Stock
Nov 01 2024	SELL Open market or private sale	$139,852 $24.28 p/Share	5,760 Reduced 17.02%	28,084 Common Stock
Nov 01 2024	BUY Exercise of conversion of derivative security	$10,713 $1.86 p/Share	5,760 Added 14.54%	33,844 Common Stock
Oct 30 2024	SELL Open market or private sale	$101,622 $24.3 p/Share	4,182 Reduced 12.96%	28,084 Common Stock
Oct 30 2024	BUY Exercise of conversion of derivative security	-	7,674 Added 19.21%	32,266 Common Stock
Oct 14 2024	SELL Open market or private sale	$82,250 $25.0 p/Share	3,290 Reduced 11.8%	24,592 Common Stock
Oct 14 2024	BUY Exercise of conversion of derivative security	$31,485 $9.57 p/Share	3,290 Added 10.55%	27,882 Common Stock
Oct 01 2024	SELL Open market or private sale	$129,600 $22.5 p/Share	5,760 Reduced 18.98%	24,592 Common Stock
Oct 01 2024	BUY Exercise of conversion of derivative security	$10,713 $1.86 p/Share	5,760 Added 15.95%	30,352 Common Stock
Sep 03 2024	SELL Open market or private sale	$228,784 $25.28 p/Share	9,050 Reduced 26.9%	24,592 Common Stock
Sep 03 2024	BUY Exercise of conversion of derivative security	$51,766 $5.72 p/Share	9,050 Added 21.2%	33,642 Common Stock
Aug 26 2024	SELL Open market or private sale	$246,848 $25.01 p/Share	9,870 Reduced 28.64%	24,592 Common Stock
Aug 26 2024	BUY Exercise of conversion of derivative security	$56,456 $5.72 p/Share	9,870 Added 22.26%	34,462 Common Stock
Aug 01 2024	SELL Open market or private sale	$125,510 $21.79 p/Share	5,760 Reduced 18.98%	24,592 Common Stock
Aug 01 2024	BUY Exercise of conversion of derivative security	$10,713 $1.86 p/Share	5,760 Added 15.95%	30,352 Common Stock
Jul 30 2024	SELL Open market or private sale	$60,356 $20.67 p/Share	2,920 Reduced 10.61%	24,592 Common Stock
Jul 30 2024	BUY Exercise of conversion of derivative security	-	7,674 Added 21.81%	27,512 Common Stock
Jul 01 2024	SELL Open market or private sale	$121,708 $21.13 p/Share	5,760 Reduced 22.5%	19,838 Common Stock
Jul 01 2024	BUY Exercise of conversion of derivative security	$10,713 $1.86 p/Share	5,760 Added 18.37%	25,598 Common Stock
Jun 13 2024	SELL Open market or private sale	$31,725 $17.02 p/Share	1,864 Reduced 8.59%	19,838 Common Stock
Jun 13 2024	BUY Exercise of conversion of derivative security	$3,467 $1.86 p/Share	1,864 Added 7.91%	21,702 Common Stock
Jun 12 2024	SELL Open market or private sale	$32,319 $17.01 p/Share	1,900 Reduced 8.74%	19,838 Common Stock
Jun 12 2024	BUY Exercise of conversion of derivative security	$3,534 $1.86 p/Share	1,900 Added 8.04%	21,738 Common Stock
Jun 05 2024	SELL Open market or private sale	$6,800 $17.0 p/Share	400 Reduced 1.98%	19,838 Common Stock

Christine Ring

Chief Legal Officer

San Francisco, CA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells NRIX shares.

Notify only if

Value

Insider Trading

Get notified when an Nurix Therapeutics, Inc. insider buys or sells NRIX shares.

Notify only if

Operation

Value

Type

News

Receive news related to Nurix Therapeutics, Inc.

Track Activities on NRIX

Account